Back to search

Article

CRISPR-Cas9 Editing of TLR4 to Improve the Outcome of Cardiac Cell Therapy

2022-07-12

Abstract excerpt

<h4>Background: </h4> Inflammation and fibrosis limit the reparative properties of human mesenchymal stromal cells (hMSCs). We hypothesized that disrupting the toll-like receptor 4 (TLR4) gene would switch hMSCs toward a reparative phenotype and improve the outcome of cell therapy for infarct repair. <h4>Methods: </h4> and results: We developed and optimized a new electroporation protocol for CRISPR-Cas9 gene edit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
551e28a3-b730-5ae8-9348-c68bb86e3d51
DOI
10.21203/rs.3.rs-1823485/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-Cas9 Editing of TLR4 to Improve the Outcome of Cardiac Cell TherapyDOI 10.21203/rs.3.rs-1823485/v1
Select a neighboring publication to make it the new centre.